Analystreport

Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $465.00 to $420.00. They now have a "buy" rati

Charles River Laboratories International, Inc.  (CRL) 
Last charles river laboratories international, inc. earnings: 2/11 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.criver.com